UBS Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$420K Buy
574,531
+205,580
+56% +$150K ﹤0.01% 4973
2025
Q1
$298K Sell
368,951
-340,048
-48% -$274K ﹤0.01% 5030
2024
Q4
$978K Buy
708,999
+535,830
+309% +$739K ﹤0.01% 4220
2024
Q3
$180K Sell
173,169
-12,371
-7% -$12.9K ﹤0.01% 4775
2024
Q2
$321K Buy
185,540
+63,670
+52% +$110K ﹤0.01% 4235
2024
Q1
$291K Sell
121,870
-22,456
-16% -$53.7K ﹤0.01% 4462
2023
Q4
$481K Sell
144,326
-164,785
-53% -$549K ﹤0.01% 4004
2023
Q3
$1.16M Buy
309,111
+306,958
+14,257% +$1.15M ﹤0.01% 2966
2023
Q2
$9.19K Sell
2,153
-203,259
-99% -$868K ﹤0.01% 6111
2023
Q1
$1.41M Sell
205,412
-100,237
-33% -$686K ﹤0.01% 2902
2022
Q4
$2.42M Buy
305,649
+260,697
+580% +$2.06M ﹤0.01% 2411
2022
Q3
$432K Sell
44,952
-71,146
-61% -$684K ﹤0.01% 3490
2022
Q2
$841K Buy
116,098
+12,237
+12% +$88.6K ﹤0.01% 2999
2022
Q1
$1.34M Sell
103,861
-59,831
-37% -$772K ﹤0.01% 2983
2021
Q4
$2.61M Buy
163,692
+40,930
+33% +$653K ﹤0.01% 2670
2021
Q3
$1.97M Buy
122,762
+70,178
+133% +$1.13M ﹤0.01% 2765
2021
Q2
$727K Sell
52,584
-68,638
-57% -$949K ﹤0.01% 3494
2021
Q1
$1.77M Buy
121,222
+108,462
+850% +$1.58M ﹤0.01% 2865
2020
Q4
$221K Sell
12,760
-3,475
-21% -$60.2K ﹤0.01% 4217
2020
Q3
$298K Sell
16,235
-7,919
-33% -$145K ﹤0.01% 3754
2020
Q2
$431K Buy
24,154
+3,352
+16% +$59.8K ﹤0.01% 3508
2020
Q1
$338K Sell
20,802
-9,759
-32% -$159K ﹤0.01% 3522
2019
Q4
$550K Sell
30,561
-2,722
-8% -$49K ﹤0.01% 3827
2019
Q3
$674K Sell
33,283
-33,141
-50% -$671K ﹤0.01% 3489
2019
Q2
$1.47M Buy
66,424
+39,794
+149% +$879K ﹤0.01% 2747
2019
Q1
$363K Sell
26,630
-181,404
-87% -$2.47M ﹤0.01% 3541
2018
Q4
$1.88M Buy
208,034
+179,492
+629% +$1.62M ﹤0.01% 2487
2018
Q3
$471K Buy
28,542
+11,679
+69% +$193K ﹤0.01% 3680
2018
Q2
$236K Sell
16,863
-64,039
-79% -$896K ﹤0.01% 3988
2018
Q1
$894K Buy
80,902
+70,000
+642% +$774K ﹤0.01% 3110
2017
Q4
$96K Sell
10,902
-7,083
-39% -$62.4K ﹤0.01% 4445
2017
Q3
$239K Buy
17,985
+6,148
+52% +$81.7K ﹤0.01% 3893
2017
Q2
$171K Buy
11,837
+9,107
+334% +$132K ﹤0.01% 3979
2017
Q1
$58K Sell
2,730
-16,251
-86% -$345K ﹤0.01% 4527
2016
Q4
$534K Buy
18,981
+14,150
+293% +$398K ﹤0.01% 3261
2016
Q3
$129K Buy
4,831
+871
+22% +$23.3K ﹤0.01% 4009
2016
Q2
$67K Buy
+3,960
New +$67K ﹤0.01% 4460
2016
Q1
Sell
-605
Closed -$14K 6704
2015
Q4
$14K Buy
+605
New +$14K ﹤0.01% 5798
2015
Q3
Sell
-2,777
Closed -$80K 6854
2015
Q2
$80K Buy
2,777
+226
+9% +$6.51K ﹤0.01% 4443
2015
Q1
$78K Buy
2,551
+1,866
+272% +$57.1K ﹤0.01% 4336
2014
Q4
$11K Buy
+685
New +$11K ﹤0.01% 5941